InvestorsObserver
×
News Home

Is Revolution Medicines Inc (RVMD) Stock a Bad Value Monday?

Monday, March 11, 2024 04:02 PM | InvestorsObserver Analysts

Mentioned in this article

Is Revolution Medicines Inc (RVMD) Stock a Bad Value Monday?

Revolution Medicines Inc (RVMD) is around the middle of the Healthcare sector according to InvestorsObserver. RVMD received an overall rating of 38, which means that it scores higher than 38% of stocks. Additionally, Revolution Medicines Inc scored a 51 in the Healthcare sector, ranking it higher than 51% of stocks in that sector.

Overall Score - 38
RVMD has an Overall Score of 38. Find out what this means to you and get the rest of the rankings on RVMD!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 38 would rank higher than 38 percent of all stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Revolution Medicines Inc Stock Today?

Revolution Medicines Inc (RVMD) stock has gained 2.08% while the S&P 500 is lower by -0.11% as of 4:00 PM on Monday, Mar 11. RVMD has gained $0.67 from the previous closing price of $32.25 on volume of 2,086,785 shares. Over the past year the S&P 500 has risen 32.74% while RVMD has gained 45.79%. RVMD lost -$3.86 per share the over the last 12 months. Click Here to get the full Stock Report for Revolution Medicines Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App